Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00041678

Enrollment

Unknown

Registered

2002-07-15

Start date

2000-01-31

Completion date

2003-03-31

Last updated

2013-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease

Keywords

Psychosis Associated with Dementia of the Alzheimer's Type

Brief summary

The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.

Interventions

DRUGaripiprazole

Study design

Primary purpose

TREATMENT

Eligibility

Sex/Gender

ALL

Age

55 Years to 95 Years

Healthy volunteers

Inclusion criteria

* Institutionalized patients with Alzheimer's Disease

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026